Amendment: SEC Form SC 13D/A filed by Bristow Group Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

---

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

(Amendment No. 10)*

---

Bristow Group Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

11040G103

(CUSIP Number)

 

Matthew L. Clark

4009 W 49th Street

Suite 300

Sioux Falls, SD 57106

605-362-2820

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

November 6, 2024

(Date of Event Which Requires Filing of This Statement)

---

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies of this statement are to be sent.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D

This Amendment No. 10 ( “Amendment No. 10”) to Schedule 13D initially filed with the Securities and Exchange Commission (the “SEC”) on June 22, 2020 (the “Schedule 13D”) by South Dakota Investment Council (the “Reporting Person”) relating to the shares of common stock, par value $0.01 per share (the “Common Stock”) of Bristow Group Inc., a Delaware corporation (the “Issuer”), reflects changes to the information in the amendment to the Schedule 13D filed by the Reporting Person on July 19, 2024 (“Amendment No.9”).  Except as otherwise indicated, capitalized terms used and not defined in this Amendment No. 10 shall have the meaning assigned to such term in the Schedule 13D. Except as otherwise provided herein, each item of the Schedule 13D remains unchanged.

Items 5(a)-(c) of the Schedule 13D are hereby amended and restated as follows:

 

(a) – (b) The responses of the Reporting Person with respect to Rows 11, 12 and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and percentage of shares of Common Stock are incorporated herein by reference. The responses of the Reporting Person with respect to Rows 7, 8, 9 and 10 of the cover pages of this Schedule 13D that relate to the aggregate number of shares of Common Stock as to which the Reporting Person referenced in Item 2 above has sole or shared power to vote or to direct the vote and sole or shared power to dispose or to direct the disposition are incorporated herein by reference.

 

The aggregate percentage of shares of Common Stock reported as beneficially owned by the Reporting Person was calculated based on 28,628,000 shares of Common Stock issued and outstanding as of November 1, 2024, as provided by the Company, based on the Quarterly Report on Form 10-Q filed by the Company on November 6, 2024.

 

(c) Except as disclosed in Exhibit 1 of this Schedule 13D, there have been no transactions with respect to the Common Stock during the sixty days prior to the date of filing of this Schedule 13D by the Reporting Person.

 

(d) None.

 

(e) Not applicable.

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

---

¹ This price reflects the weighted average price for open-market sales of Common Stock made by the Reporting Person on November 6, 2024 within a $1.00 range.

² This price reflects the weighted average price for open-market sales of Common Stock made by the Reporting Person on November 6, 2024 within a $1.00 range.

---